Post Doc

Research Group Home Page: 

After completing his BsC+MSc in Biology from the University of Lisbon (Portugal) Filipe started his PhD in the University of Lyon (France). During his PhD in Patrick Mehlen’s laboratory at the Centre de Recherche en Cancerologie de Lyon Filipe found a new functional ligand for the Amyloid Precursor Protein (APP), a key protein in Alzheimer’s disease.

With his PhD in hand Filipe then moved to Mike Olson’s laboratory at the CRUK Beatson Institute in Glasgow (Scotland) to work in the role of F-actin dynamics in intestinal stem biology as well as colorectal cancer initiation and progression.

Filipe joined Winton Group in 2013 and since then he has been  interested in understanding and modelling colorectal cancer initiation in mouse models using chemical mutagenesis.

Work address: 
Cancer Research UK Cambridge Institute University of Cambridge Li Ka Shing Centre Robinson Way Cambridge CB2 0RE
Publications: 

Three-Dimensional Printed Molds for Image-Guided Surgical Biopsies: An Open Source Computational Platform.

E-pub date: 31 Aug 2020


T2-Hypointense Adnexal Lesions: An Imaging Algorithm (vol 40, pg 1200, 2020)

E-pub date: 01 Aug 2020


Integrative radiogenomics for virtual biopsy and treatment monitoring in ovarian cancer.

E-pub date: 31 Jul 2020


T2-Hypointense Adnexal Lesions: An Imaging Algorithm.

E-pub date: 01 Jul 2020


Unraveling tumor-immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy.

E-pub date: 08 Jun 2020


Comparison of likert and PI-RADS version 2 MRI scoring systems for the detection of clinically significant prostate cancer.

E-pub date: 31 May 2020


Recent advances of HCI in decision-making tasks for optimized clinical workflows and precision medicine.

E-pub date: 31 May 2020


The emerging role of cell surface receptor and protein binding radiopharmaceuticals in cancer diagnostics and therapy.

E-pub date: 31 May 2020


Integration of proteomics with CT-based qualitative and radiomic features in high-grade serous ovarian cancer patients: an exploratory analysis.

E-pub date: 31 Mar 2020


Diagnostic accuracy of biparametric versus multiparametric prostate MRI: assessment of contrast benefit in clinical practice.

E-pub date: 29 Feb 2020


Radiomics of computed tomography and magnetic resonance imaging in renal cell carcinoma-a systematic review and meta-analysis.

E-pub date: 31 Jan 2020


Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors.

E-pub date: 31 Jan 2020


MRI of Bladder Cancer: Local and Nodal Staging.

E-pub date: 31 Jan 2020


Imaging breast cancer using hyperpolarized carbon-13 MRI.

E-pub date: 31 Dec 2019


The effect of capped biparametric magnetic resonance imaging slots on weekly prostate cancer imaging workload.

E-pub date: 31 Dec 2019


A hybrid end-to-end approach integrating conditional random fields into CNNs for prostate cancer detection on MRI

E-pub date: 31 Dec 2019


Measuring Tumor Glycolytic Flux in Vivo by Using Fast Deuterium MRI.

E-pub date: 30 Nov 2019


Does the method of primary treatment affect the pattern of first recurrence in high-grade serous ovarian cancer?

E-pub date: 31 Aug 2019


MRI of Tumors and Tumor Mimics in the Female Pelvis: Anatomic Pelvic Space-based Approach.

E-pub date: 01 Jul 2019


Feasibility of Quantitative Magnetic Resonance Fingerprinting in Ovarian Tumors for T1 and T2 Mapping in a PET/MR Setting.

E-pub date: 01 Jul 2019


Three-year experience of a dedicated prostate mpMRI pre-biopsy programme and effect on timed cancer diagnostic pathways.

E-pub date: 30 Jun 2019


Diffusion kurtosis MRI as a predictive biomarker of response to neoadjuvant chemotherapy in high grade serous ovarian cancer.

E-pub date: 30 Jun 2019


Radiomics: an Introductory Guide to What It May Foretell.

E-pub date: 31 May 2019


How clinical imaging can assess cancer biology.

E-pub date: 28 Feb 2019


Abbreviated MRI Protocols for the Abdomen.

E-pub date: 28 Feb 2019


Single-dose radiotherapy disables tumor cell homologous recombination via ischemia/reperfusion injury.

E-pub date: 31 Jan 2019


Repeatability of diffusion-weighted MRI of the prostate using whole lesion ADC values, skew and histogram analysis.

E-pub date: 01 Jan 2019


Sodium MRI with 3D-cones as a measure of tumour cellularity in high grade serous ovarian cancer.

E-pub date: 01 Jan 2019


HaraliCU: GPU-powered Haralick feature extraction on medical images exploiting the full dynamics of gray-scale levels

E-pub date: 31 Dec 2018


A Survey on Nature-Inspired Medical Image Analysis: A Step Further in Biomedical Data Integration

E-pub date: 31 Dec 2018


Radiogenomics analysis of intratumor heterogeneity in a patient with high-grade serous ovarian cancer

E-pub date: 31 Dec 2018


Computed tomography-derived radiomic metrics can identify responders to immunotherapy in ovarian cancer

E-pub date: 31 Dec 2018


Ovarian cancer: An update on imaging in the era of radiomics.

E-pub date: 30 Nov 2018


Association between CT-texture-derived tumor heterogeneity, outcomes, and BRCA mutation status in patients with high-grade serous ovarian cancer.

E-pub date: 31 Oct 2018


Photogenerated Radical in Phenylglyoxylic Acid for in Vivo Hyperpolarized 13C MR with Photosensitive Metabolic Substrates.

E-pub date: 30 Sep 2018


Unraveling Tumor-Immune Heterogeneity in Advanced Ovarian Cancer Uncovers Immunogenic Effect of Chemotherapy

E-pub date: 30 Sep 2018


Glyoxalase activity in human erythrocytes and mouse lymphoma, liver and brain probed with hyperpolarized 13C-methylglyoxal.

E-pub date: 01 Aug 2018


Structured reporting of pelvic MRI leads to better treatment planning of uterine leiomyomas.

E-pub date: 31 Jul 2018


Endometrial Cancer MRI staging: Updated Guidelines of the European Society of Urogenital Radiology.

E-pub date: 30 Jun 2018


Metabolic imaging detects low levels of glycolytic activity that vary with levels of c-Myc expression in patient-derived xenograft models of glioblastoma.

E-pub date: 30 Jun 2018


MR Imaging of Rectal Cancer: Radiomics Analysis to Assess Treatment Response after Neoadjuvant Therapy.

E-pub date: 01 Jun 2018


CT Features of Ovarian Tumors: Defining Key Differences Between Serous Borderline Tumors and Low-Grade Serous Carcinomas.

E-pub date: 01 Apr 2018


Translational Radiomics: Defining the Strategy Pipeline and Considerations for Application-Part 2: From Clinical Implementation to Enterprise.

E-pub date: 01 Mar 2018


Translational Radiomics: Defining the Strategy Pipeline and Considerations for Application-Part 1: From Methodology to Clinical Implementation.

E-pub date: 01 Mar 2018


Background, current role, and potential applications of radiogenomics.

E-pub date: 01 Mar 2018


Dynamic 1 H imaging of hyperpolarized [1-13 C]lactate in vivo using a reverse INEPT experiment.

E-pub date: 01 Feb 2018


Erratum to: Fertility-sparing for young patients with gynecologic cancer: How MRI can guide patient selection prior to conservative management.

E-pub date: 01 Dec 2017


High-Grade Serous Ovarian Cancer: Associations between BRCA Mutation Status, CT Imaging Phenotypes, and Clinical Outcomes.

E-pub date: 01 Nov 2017


Radiogenomics of High-Grade Serous Ovarian Cancer: Multireader Multi-Institutional Study from the Cancer Genome Atlas Ovarian Cancer Imaging Research Group.

E-pub date: 01 Nov 2017


Fertility-sparing for young patients with gynecologic cancer: How MRI can guide patient selection prior to conservative management.

E-pub date: 01 Oct 2017


A novel representation of inter-site tumour heterogeneity from pre-treatment computed tomography textures classifies ovarian cancers by clinical outcome.

E-pub date: 01 Sep 2017


From Staging to Prognostication: Achievements and Challenges of MR Imaging in the Assessment of Endometrial Cancer.

E-pub date: 31 Aug 2017


Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient.

E-pub date: 24 Aug 2017


The performance of PI-RADSv2 and quantitative apparent diffusion coefficient for predicting confirmatory prostate biopsy findings in patients considered for active surveillance of prostate cancer.

E-pub date: 01 Jul 2017


Differentiation of Uterine Leiomyosarcoma from Atypical Leiomyoma: Diagnostic Accuracy of Qualitative MR Imaging Features and Feasibility of Texture Analysis.

E-pub date: 01 Jul 2017


Combined Whole Body and Multiparametric Prostate Magnetic Resonance Imaging as a 1-Step Approach to the Simultaneous Assessment of Local Recurrence and Metastatic Disease after Radical Prostatectomy.

E-pub date: 01 Jul 2017


Abdominal wall endometriosis: differentiation from other masses using CT features.

E-pub date: 01 May 2017


Renal Masses Detected on FDG PET/CT in Patients With Lymphoma: Imaging Features Differentiating Primary Renal Cell Carcinomas From Renal Lymphomatous Involvement.

E-pub date: 01 Apr 2017


Rationale for Modernising Imaging in Advanced Prostate Cancer.

E-pub date: 01 Apr 2017


Heterogeneous fates of metastatic lesions linked to immune escape in an ovarian cancer patient

E-pub date: 01 Mar 2017


Unravelling tumour heterogeneity using next-generation imaging: radiomics, radiogenomics, and habitat imaging.

E-pub date: 31 Jan 2017


Prostate cancer bone metastases on staging prostate MRI: prevalence and clinical features associated with their diagnosis.

E-pub date: 01 Jan 2017


METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate Cancer.

E-pub date: 01 Jan 2017


Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study.

E-pub date: 31 Dec 2016


Localizing sites of disease in patients with rising serum prostate-specific antigen up to 1ng/ml following prostatectomy: How much information can conventional imaging provide?

E-pub date: 01 Nov 2016


Evaluating Prostate Cancer Using Fractional Tissue Composition of Radical Prostatectomy Specimens and Pre-Operative Diffusional Kurtosis Magnetic Resonance Imaging.

E-pub date: 31 Aug 2016


Second-Opinion Interpretations of Gynecologic Oncologic MRI Examinations by Sub-Specialized Radiologists Influence Patient Care.

E-pub date: 01 Jul 2016


Molecular Imaging of Ovarian Cancer.

E-pub date: 01 Jun 2016


Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference.

E-pub date: 01 Jun 2016


The expanding landscape of diffusion-weighted MRI in prostate cancer.

E-pub date: 01 May 2016


Preclinical 89Zr Immuno-PET of High-Grade Serous Ovarian Cancer and Lymph Node Metastasis.

E-pub date: 01 May 2016


Circulating tumour DNA carrying patient-specific mutations in TP53 as an early response biomarker in relapsed high grade serous ovarian cancer.

E-pub date: 30 Apr 2016


Diagnostic Performance of Computed Tomography for Preoperative Staging of Patients with Non-endometrioid Carcinomas of the Uterine Corpus.

E-pub date: 01 Apr 2016


MR Imaging in the Assessment of Endometrial Cancer.

E-pub date: 01 Apr 2016


The Wheel of the Mesentery: Imaging Spectrum of Primary and Secondary Mesenteric Neoplasms–How Can Radiologists Help Plan Treatment?: Resident and Fellow Education Feature.

E-pub date: 31 Mar 2016


Is It Time to Centralize Ovarian Cancer Care in the United States?

E-pub date: 01 Mar 2016


The impact of FDG-PET/CT in the management of patients with vulvar and vaginal cancer.

E-pub date: 01 Mar 2016


Invasion Patterns of Metastatic Extrauterine High-grade Serous Carcinoma With BRCA Germline Mutation and Correlation With Clinical Outcomes.

E-pub date: 01 Mar 2016


Functional MR Imaging Techniques in Oncology in the Era of Personalized Medicine.

E-pub date: 01 Feb 2016


Molecular Imaging of Prostate Cancer.

E-pub date: 01 Jan 2016


Is it time to centralize ovarian cancer care in the United States?

E-pub date: 31 Dec 2015


Ratio of Tumor to Normal Prostate Tissue Apparent Diffusion Coefficient as a Method for Quantifying DWI of the Prostate.

E-pub date: 31 Dec 2015


Imaging Features of Uncommon Gynecologic Cancers.

E-pub date: 01 Dec 2015


Extreme Outlier Analysis Identifies Occult Mitogen-Activated Protein Kinase Pathway Mutations in Patients With Low-Grade Serous Ovarian Cancer.

E-pub date: 30 Nov 2015


Volume-based quantitative FDG PET/CT metrics and their association with optimal debulking and progression-free survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery.

E-pub date: 01 Nov 2015


Automatic classification of prostate cancer Gleason scores from multiparametric magnetic resonance images.

E-pub date: 31 Oct 2015


Ovarian Cancer from Anatomy to Functional Imaging

E-pub date: 31 Oct 2015


Haralick texture analysis of prostate MRI: utility for differentiating non-cancerous prostate from prostate cancer and differentiating prostate cancers with different Gleason scores.

E-pub date: 01 Oct 2015


Complementary Prognostic Value of Pelvic Magnetic Resonance Imaging and Whole-Body Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Pretreatment Assessment of Patients With Cervical Cancer.

E-pub date: 01 Oct 2015


Endometrial Cancer: Combined MR Volumetry and Diffusion-weighted Imaging for Assessment of Myometrial and Lymphovascular Invasion and Tumor Grade.

E-pub date: 01 Sep 2015


Incorporation of postoperative CT data into clinical models to predict 5-year overall and recurrence free survival after primary cytoreductive surgery for advanced ovarian cancer.

E-pub date: 01 Sep 2015


Preoperative CT-based nomogram for predicting overall survival in women with non-endometrioid carcinomas of the uterine corpus.

E-pub date: 31 Aug 2015


Diagnosis of Extracapsular Extension of Prostate Cancer on Prostate MRI: Impact of Second-Opinion Readings by Subspecialized Genitourinary Oncologic Radiologists.

E-pub date: 01 Jul 2015


Role of MR Imaging and FDG PET/CT in Selection and Follow-up of Patients Treated with Pelvic Exenteration for Gynecologic Malignancies.

E-pub date: 01 Jul 2015


Molecular imaging of prostate cancer: translating molecular biology approaches into the clinical realm.

E-pub date: 01 May 2015


Association between morphologic CT imaging traits and prognostically relevant gene signatures in women with high-grade serous ovarian cancer: a hypothesis-generating study.

E-pub date: 01 Mar 2015


Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis.

E-pub date: 01 Feb 2015


Intradiverticular bladder cancer: CT imaging features and their association with clinical outcomes.

E-pub date: 01 Jan 2015


Imaging in gynecology

E-pub date: 31 Dec 2014


Multiparametric 3T MRI for the prediction of pathological downgrading after radical prostatectomy in patients with biopsy-proven Gleason score 3 + 4 prostate cancer.

E-pub date: 01 Dec 2014


Association between penile dynamic contrast-enhanced MRI-derived quantitative parameters and self-reported sexual function in patients with newly diagnosed prostate cancer.

E-pub date: 01 Oct 2014


Preoperative 3-T diffusion-weighted MRI for the qualitative and quantitative assessment of extracapsular extension in patients with intermediate- or high-risk prostate cancer.

E-pub date: 01 Sep 2014


Prostate cancer: performance characteristics of combined T₂W and DW-MRI scoring in the setting of template transperineal re-biopsy using MR-TRUS fusion.

E-pub date: 31 Jul 2014


Bevacizumab shows activity in patients with low-grade serous ovarian and primary peritoneal cancer.

E-pub date: 31 Jul 2014


Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer.

E-pub date: 01 Jul 2014


Repeatability of quantitative FDG-PET/CT and contrast-enhanced CT in recurrent ovarian carcinoma: test-retest measurements for tumor FDG uptake, diameter, and volume.

E-pub date: 15 May 2014


Role of imaging in the pretreatment evaluation of common gynecological cancers.

E-pub date: 01 May 2014


Role of molecular imaging in the era of personalized medicine: A review

E-pub date: 31 Dec 2013


Acute effects of pelvic irradiation on the adult uterus revealed by dynamic contrast-enhanced MRI.

E-pub date: 01 Nov 2013


Malignant conditions of the vulva

E-pub date: 31 Oct 2013


Uterus: Follow-up and detection of recurrent disease

E-pub date: 31 Oct 2013


Uterus: Imaging techniques and normal anatomy

E-pub date: 31 Oct 2013


Malignant neoplasms, staging of ovarian cancer

E-pub date: 31 Oct 2013


Congenital uterine anomalies

E-pub date: 31 Oct 2013


Magnetic resonance imaging/positron emission tomography provides a roadmap for surgical planning and serves as a predictive biomarker in patients with recurrent gynecological cancers undergoing pelvic exenteration.

E-pub date: 01 Oct 2013


Role of preoperative MR imaging in the evaluation of patients with persistent or recurrent gynaecological malignancies before pelvic exenteration.

E-pub date: 01 Oct 2013


The value of 18F-FDG PET/CT in recurrent gynecologic malignancies prior to pelvic exenteration.

E-pub date: 01 Jun 2013


The added role of MR imaging in treatment stratification of patients with gynecologic malignancies: what the radiologist needs to know.

E-pub date: 31 Mar 2013


MRI of ovarian masses.

E-pub date: 01 Feb 2013


Pearls and pitfalls in MRI of gynecologic malignancy with diffusion-weighted technique.

E-pub date: 01 Feb 2013


Puberty reveals a familial disorder of sex development.

E-pub date: 31 Oct 2012


Assessment of ovarian movement on consecutive pelvic MRI examinations in patients with gynaecological malignancies: what is the planning organ-at-risk volume for radiotherapy?

E-pub date: 31 Oct 2012


The revised FIGO staging system for uterine malignancies: implications for MR imaging.

E-pub date: 31 Oct 2012


Ovarian carcinomatosis: how the radiologist can help plan the surgical approach.

E-pub date: 31 Oct 2012


T2-hypointense adnexal lesions: an imaging algorithm.

E-pub date: 31 Jul 2012


Vascular invasion in hepatocellular carcinoma: is there a correlation with MRI?

E-pub date: 01 Jun 2012


Advanced ovarian cancer: multiparametric MR imaging demonstrates response- and metastasis-specific effects.

E-pub date: 01 Apr 2012


DCE and DW MRI in monitoring response to androgen deprivation therapy in patients with prostate cancer: a feasibility study.

E-pub date: 31 Mar 2012


Evaluation of depth of myometrial invasion and overall staging in endometrial cancer: comparison of diffusion-weighted and dynamic contrast-enhanced MR imaging.

E-pub date: 01 Feb 2012


FIGO staging system for endometrial cancer: added benefits of MR imaging.

E-pub date: 31 Jan 2012


The emerging role of diffusion-weighted MRI in prostate cancer management.

E-pub date: 17 Jan 2012


Magnetic resonance imaging of the cervix, and its relevance to the revised International Federation of Gynecology and Obstetrics (FIGO) staging

E-pub date: 31 Dec 2011


Thoracic metastasis in advanced ovarian cancer: comparison between computed tomography and video-assisted thoracic surgery.

E-pub date: 01 Dec 2011


Female pelvis

E-pub date: 30 Nov 2011


Clinical MRI of the abdomen: Why,how,when

E-pub date: 30 Nov 2011


MRI at the completion of chemoradiotherapy can accurately evaluate the extent of disease in women with advanced urethral carcinoma undergoing anterior pelvic exenteration.

E-pub date: 01 Nov 2011


A pilot study using transvaginal real-time ultrasound elastography to evaluate the postmenopausal endometrium.

E-pub date: 31 Aug 2011


The role of functional MRI and PET/CT in evaluation of patients with primary and recurrent ovarian cancer

E-pub date: 31 May 2011


Staging of uterine cervical cancer with MRI: guidelines of the European Society of Urogenital Radiology.

E-pub date: 31 May 2011


Pharmacodynamic study of antiangiogenic therapy in patients with renal cell carcinoma.

E-pub date: 30 Apr 2011


Imaging: standardizing the use of functional MRI in prostate cancer.

E-pub date: 31 Mar 2011


Role of MRI in intracavitary brachytherapy for cervical cancer: what the radiologist needs to know.

E-pub date: 31 Mar 2011


Advances in magnetic resonance imaging of endometrial cancer.

E-pub date: 31 Mar 2011


T1-weighted fat-suppressed imaging of the pelvis with a dual-echo Dixon technique: initial clinical experience.

E-pub date: 01 Feb 2011


Intra-tumour genetic heterogeneity and poor chemoradiotherapy response in cervical cancer.

E-pub date: 18 Jan 2011


Functional imaging: From tumour biology to the clinic

E-pub date: 31 Dec 2010


ESUR guidelines: ovarian cancer staging and follow-up.

E-pub date: 31 Dec 2010


The role of dynamic contrast-enhanced and diffusion weighted magnetic resonance imaging in the female pelvis.

E-pub date: 31 Dec 2010


Prostate cancer metabolite quantification relative to water in (1)H-MRSI in vivo at 3 Tesla.

E-pub date: 16 Nov 2010


Pelvic imaging following chemotherapy and radiation therapy for gynecologic malignancies.

E-pub date: 01 Nov 2010


Magnetic resonance imaging for the evaluation of acute abdominal pain in pregnancy.

E-pub date: 31 Oct 2010


Radiological staging of ovarian carcinoma.

E-pub date: 31 Oct 2010


Congenital and acquired conditions of the vulva and vagina on magnetic resonance imaging: a pictorial review.

E-pub date: 31 Oct 2010


Adnexal masses: characterization and imaging strategies.

E-pub date: 31 Oct 2010


Recurrent ovarian cancer: use of contrast-enhanced CT and PET/CT to accurately localize tumor recurrence and to predict patients’ survival.

E-pub date: 31 Oct 2010


Ovarian cancer: the role of functional imaging as an end point in clinical trials.

E-pub date: 31 Aug 2010


Evaluation of nonenhancing tumor fraction assessed by dynamic contrast-enhanced MRI subtraction as a predictor of decrease in tumor volume in response to chemoradiotherapy in advanced cervical cancer.

E-pub date: 31 Aug 2010


Nonovarian cystic lesions of the pelvis.

E-pub date: 31 Jul 2010


Visceral abdominal obesity–is there an increased prevalence in men presenting with testicular teratoma?

E-pub date: 31 Jul 2010


Primary neuroendocrine carcinoma of the Bartholin’s gland: Magnetic resonance imaging findings with pathologic correlation

E-pub date: 30 Jun 2010


Dynamic contrast-enhanced MRI in ovarian cancer: Initial experience at 3 tesla in primary and metastatic disease.

E-pub date: 01 Apr 2010


The accuracy of magnetic resonance imaging in staging of vulvar cancer: a retrospective multi-centre study.

E-pub date: 01 Apr 2010


Apparent diffusion coefficient and vascular signal fraction measurements with magnetic resonance imaging: feasibility in metastatic ovarian cancer at 3 Tesla: technical development.

E-pub date: 01 Feb 2010


Unexpected changes in clinical diagnosis: early abdomino-pelvic computed tomography compared with clinical evaluation.

E-pub date: 01 Nov 2009


Metabolic characterization of primary and metastatic ovarian cancer by 1H-MRS in vivo at 3T.

E-pub date: 31 Oct 2009


Imaging of the female pelvis

E-pub date: 30 Sep 2009


Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer.

E-pub date: 01 Jul 2009


If the scan fits–evacuate!

E-pub date: 01 Apr 2009


Imaging of Abnormal Uterine Bleeding

E-pub date: 28 Feb 2009


Image-guided biopsy in patients with suspected ovarian carcinoma: a safe and effective technique?

E-pub date: 31 Jan 2009


Added value of dynamic contrast-enhanced magnetic resonance imaging in predicting advanced stage disease in patients with endometrial carcinoma.

E-pub date: 31 Jan 2009


Imaging in gynaecological oncology

E-pub date: 31 Dec 2008


Radiology for surgeons in clinical practice

E-pub date: 30 Nov 2008


[MRI of malignant neoplasms of the uterine corpus and cervix].

E-pub date: 01 Nov 2008


Magnetic resonance imaging of the female pelvis.

E-pub date: 31 Oct 2008


Lossy 3D JPEG2000 compression of abdominal CT images in patients with acute abdominal complaints: effect of compression ratio on diagnostic confidence and accuracy.

E-pub date: 31 Aug 2008


Perihepatic metastases from ovarian cancer: sensitivity and specificity of CT for the detection of metastases with and those without liver parenchymal invasion.

E-pub date: 31 Aug 2008


Magnetic Resonance Imaging Findings of Tamoxifen-Associated Uterine Mullerian Adenosarcoma: A Case Report.

E-pub date: 02 Jun 2008


Re: A randomized, controlled trial of routine early abdominal computed tomography in patients presenting with non-specific acute abdominal pain. A reply

E-pub date: 01 May 2008


Mammographic density using two computer-based methods in an isoflavone trial.

E-pub date: 20 Apr 2008


A randomized, controlled trial of routine early abdominal computed tomography in patients presenting with non-specific acute abdominal pain.

E-pub date: 31 Oct 2007


Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging.

E-pub date: 01 Jun 2006


Endorectal MR imaging in the evaluation of seminal vesicle invasion: diagnostic accuracy and multivariate feature analysis.

E-pub date: 01 Mar 2006


Endorectal MR imaging before salvage prostatectomy: tumor localization and staging.

E-pub date: 01 Jan 2006


Ankylosing spondylitis: an unusual cause for complete heart block (2005 : 10b)

E-pub date: 01 Jan 2006


Incidental detection of an autonomous nodule in a retrosternal goiter on F-18 FDG positron emission tomography.

E-pub date: 01 Nov 2004


Incidental bronchogenic cyst detected on F-18 FDG positron emission tomography.

E-pub date: 31 Aug 2004


Deterministic models for breast cancer progression: application to the association between mammographic parenchymal pattern and histologic grade of breast cancers.

E-pub date: 01 Nov 2002


Mammographic parenchymal patterns and breast cancer natural history–a case-control study.

E-pub date: 01 Aug 2001


Estimation of disease progression parameters from case-control data: application to mammographic patterns and breast cancer natural history.

E-pub date: 01 Aug 2001


High-risk mammographic parenchymal patterns, hormone replacement therapy and other risk factors: a case-control study.

E-pub date: 31 Aug 2000


Thyroid cancer in the age group 0-19: time trends and temporal changes in radioactive fallout.

E-pub date: 01 Aug 1993


Show all